Press Releases

ImPACT Applications Increases its Support of Concussion Studies at Harvard Medical School and Spaulding Rehabilitation Hospital

08/02/2017

A Worldwide Leader in Concussion Management Increases Support of Accelerate Knowledge/Improve Care: Concussion Research Program ImPACT Applications, Inc., developer of FDA-approved ImPACT®, FDA-approved ImPACT Pediatric®, FDA-approved ImPACT Quick Test™, and the ImPACT Passport app, announced its increased support of the Accelerate Knowledge/Improve Care: Concussion Research Program established by the Spaulding Rehabilitation Hospital and Harvard Medical…

Read More

ImPACT Applications Earns Provisional Accreditation from the Accreditation Council for Continuing Medical Education to Provide Courses for Physicians and Healthcare Providers

01/18/2017

Leader in Computerized Neurocognitive Testing Offers Training and Educational Resources for Concussion Management Tools San Diego, Calif. – ImPACT Applications, Inc., developer of ImPACT® and ImPACT Pediatric®, announced today it has been granted Provisional Accreditation by the Accreditation Council for Continuing Medical Education (ACCME®) to provide Continuing Medical Education (CME) courses on concussion management for…

Read More

ImPACT Applications Exceeds 12 Millionth Neurocognitive Test

12/14/2016

Celebrates History of Innovation in Concussion Management Technology Development ImPACT Applications, developer of ImPACT® (Immediate Post-Concussion Assessment and Cognitive Test), ImPACT Pediatric®, and ImPACT Passport™, announced today that more than 12 million of its ImPACT baseline and post-injury neurocognitive tests have been administered since the release of the test in 2006. In the past year…

Read More

ImPACT Applications Expands in UK with The Football Association and the IFFDC to Improve Concussion Management For Hundreds of Thousands of Athletes

12/06/2016

Worldwide Leader in Neurocognitive Testing to Help UK Youth and Professional Football Clubs Set Higher Player Safety Standards Pittsburgh, Pa. and London, UK – December 6, 2016 – ImPACT Applications, Inc., developer of ImPACT®, ImPACT Pediatric®, and ImPACT Passport™, proudly announces new partnerships with the UK-based football (soccer) governing body The Football Association (The FA) and the International…

Read More

American Psychological Association Approves ImPACT Applications as a Sponsor for Continuing Education Courses for Psychologists

11/17/2016

Worldwide Leader in Computerized Neurocognitive Testing Offers Training and Educational Resources for the use of ImPACT Applications’ Products in Concussion Management ImPACT Applications, Inc., developer of FDA-cleared ImPACT® and ImPACT Pediatric®, announced today it is approved by the American Psychological Association to sponsor continuing education for psychologists. ImPACT Applications, Inc. maintains responsibility for this program…

Read More

ImPACT Applications Supports Concussion Studies at Harvard Medical School and Spaulding Rehabilitation Hospital

09/20/2016

A Worldwide Leader in Neurocognitive Testing Offers Funding to Accelerate Knowledge/Improve Care: Concussion Research Program ImPACT Applications, Inc., developer of FDA-approved ImPACT®, FDA-approved ImPACT Pediatric®, and ImPACT Passport, announced today it will donate $600,000 over the next three years to the Accelerate Knowledge/Improve Care: Concussion Research Program established by the Spaulding Rehabilitation Hospital and Harvard…

Read More

ImPACT Applications Launches First Pediatric Medical Device for Concussion Management

08/24/2016

FDA–Cleared ImPACT Pediatric® Sets Standard for Cognitive Skills Testing for Children Ages 5-11 ImPACT Applications announces ImPACT Pediatric, its newest innovation in the field of concussion management. The first and only FDA-approved concussion-specific tool designed for individuals ages 5-11, ImPACT Pediatric provides healthcare professionals with objective measures of neurocognitive functioning for evaluation and management of…

Read More

ImPACT® Is The First Concussion-Specific Medical Device to Receive FDA Clearance

08/23/2016

ImPACT, the most widely-used and most scientifically-validated computerized neurocognitive concussion management tool available, is the first medical device of its kind to receive U.S. Food and Drug Administration (FDA) de novo clearance. FDA clearance has been granted under Computerized Cognitive Assessment Aid for Concussion, a new category for a device that uses an individual’s score(s) on a…

Read More

ImPACT Applications and Dave Duerson Athletic Safety Fund to Deliver Baseline and Post-Injury Testing to Underserved Schools

07/26/2016

ImPACT Applications, Inc., developer of ImPACT®, ImPACT Passport, and the ImPACT Concussion Management Model™, proudly announces a new partnership with the Dave Duerson Athletic Safety Fund, Inc. (DDASF) to provide underserved schools across the United States with critical components of concussion management: baseline and post-injury testing. During the 2016-2017 academic year, DDASF plans to offer…

Read More

ImPACT Applications Sponsors Inaugural Dignity Health Foundation Humankindness Gala to Support Concussion Education

05/26/2016

Pittsburgh, Pa. and San Francisco – May 26, 2016 – ImPACT Applications, Inc., developer of ImPACT®, ImPACT Passport, and the ImPACT Concussion Management Model™, helped support Dignity Health’s Concussion Education initiative as a sponsor of the organization’s inaugural Dignity Health Foundation Humankindness Gala on May 19, 2016 at San Francisco City Hall. “We are so pleased to have ImPACT…

Read More